Omaxe Ltd
Omaxe Q4 FY17 earnings call: Revenue & Margins
Q4 FY17 investor presentation: what the company reported on revenue, margins and projects.
Based on Omaxe Ltd's Q4 FY17 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4 FY17 Income from Operations: ₹468 Cr, up from ₹391 Cr in Q4 FY16. Q4 FY17 EBITDA: ₹58 Cr, down from ₹81 Cr in Q4 FY16 (28.4% decrease) [Page 12 & 11] - Q4 FY17 PAT: ₹13 Cr, down from ₹29 Cr in Q4 FY16 (55.2% decrease) [Page 12 & 11] - Q4 FY17 Turnover: ₹468 Cr, up from ₹391 Cr in Q4 FY16 (19.7% increase) [Page 11] - Operating margin for Q4 FY17 can be approximated as EBITDA/Turnover = 12.4% (₹58 Cr / ₹468 Cr), compared to 20.7% in Q4 FY16 (₹81 Cr / ₹391 Cr) [Calculated from Page 11 & 12] - The presentation does not explicitly state any forward-looking operating margin or EBITDA margin outlook.
From Omaxe Ltd's Q4 FY17 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4 FY17 Income from Operations: ₹468 Cr, up from ₹391 Cr in Q4 FY16.
- Q4 FY17 EBITDA: ₹58 Cr, down from ₹81 Cr in Q4 FY16.
- Q4 FY17 PAT: ₹13 Cr, down from ₹29 Cr in Q4 FY16.
- Q4 FY17 Area booked: 0.80 mn sqft, down 39% from 1.32 mn sqft in Q4 FY16.
- Q4 FY17 Value of booking: ₹154 Cr, down 51% from ₹313 Cr in Q4 FY16.
- Average rate psf in Q4 FY17: ₹1,914, down 19% from ₹2,368 in Q4 FY16.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Omaxe Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Realty
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Omaxe Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- For FY17, Omaxe Limited reported:
- Area Sold (Order Book): 3.20 million sq.ft (down 35% from 4.89 mn sq.ft in FY16)
- Value of Booking (Order Inflow): Rs. 946 crore (down 43% from Rs. 1,648 cr in FY16)
- Average Rate per sq.ft: Rs. 2,956 (down 12% from Rs. 3,372 in FY16) (Page 8)
- For Q4 FY17:
- Area Sold (Order Book): 0.80 million sq.ft (down 39% from 1.32 mn sq.ft in Q4 FY16)
- Value of Booking (Order Inflow): Rs. 154 crore (down 51% from Rs. 313 cr in Q4 FY16)
2 more points management made on order book & pipeline
Omaxe Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹349 Cr, net loss ₹191 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Omaxe Ltd's management said in earlier quarters
Frequently Asked Questions
What were Omaxe Ltd Q4 FY17 results?
Q4 FY17 Income from Operations: ₹468 Cr, up from ₹391 Cr in Q4 FY16. Q4 FY17 EBITDA: ₹58 Cr, down from ₹81 Cr in Q4 FY16 (28.4% decrease) [Page 12 & 11] - Q4 FY17 PAT: ₹13 Cr, down from ₹29 Cr in Q4 FY16 (55.2% decrease) [Page 12 & 11] - Q4 FY17 Turnover: ₹468 Cr, up from ₹391 Cr in Q4 FY16 (19.7% increase) [Page 11] - Operating margin for Q4 FY17 can be approximated as EBITDA/Turnover = 12.4% (₹58 Cr / ₹468 Cr), compared to 20.7% in Q4 FY16 (₹81 Cr / ₹391 Cr) [Calculated from Page 11 & 12] - The presentation does not explicitly state any forward-looking operating margin or EBITDA margin outlook.
What is Omaxe Ltd share price analysis?
Omaxe Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,146 Cr. Investors should review the full earnings analysis for detailed insights.
Is Omaxe Ltd planning capital expenditure?
The presentation does not explicitly mention any capex, capacity expansion, or new plant/project details with amounts, status, and timelines.
Keep Omaxe Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.